Disclosure Of Entity's Operating Segments [Text Block]

Biotest AG - Filing #6464577

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	Fehlerkorrektur nach IAS 8.41 ff.	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	7,262,000,000 EUR	—	—	—	—	—	—	—	6,846,000,000 EUR	—	—	—	—	—
Tax expense (income)	202,000,000 EUR	—	—	—	—	—	—	—	207,000,000 EUR	—	—	—	—	—
Profit (loss) before tax	465,000,000 EUR	—	—	—	—	—	—	—	1,063,000,000 EUR	—	—	—	—	—
Profit (loss)	264,000,000 EUR	– EUR	– EUR	—	– EUR	– EUR	264,000,000 EUR	– EUR	1,270,000,000 EUR	—	– EUR	– EUR	1,270,000,000 EUR	– EUR
Assets	—	—	—	1,434,000 EUR	—	—	—	—	—	1,410,900 EUR	—	—	—	—
Liabilities	—	—	—	9,033,000,000 EUR	—	—	—	—	—	9,120,000,000 EUR	—	—	—	—
Cash flows from (used in) operating activities	609,000,000 EUR	—	—	—	—	—	—	—	27,000,000 EUR	—	—	—	—	—
Cash flows from (used in) investing activities	257,000,000 EUR	—	—	—	—	—	—	—	13,000,000 EUR	—	—	—	—	—
Cash flows from (used in) financing activities	354,000,000 EUR	—	—	—	—	—	—	—	68,000,000 EUR	—	—	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]